QUADRACEL 0.5 mL injection vial, Sanofi Pasteur Australia Pty Ltd, CON-75

          This consent applies only to 24000 doses from Quadracel final bulk Lot C5146B (expiry on 2 September 2018);       Non-compliance with the European Pharmacopoeia (Ph. Eur.) requirements is limited to the tests detailed in the application;       The doses will be labelled in the Australian approved labels (carton, vial and package insert);       The company will provide TGA with a copy of the Release Certificate of the above batch from US CBER;       Normal TGA lot release processes will apply to this batch.         #160;